Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

[1]  W. Dougall,et al.  Interaction of the neu/p185 and EGF receptor tyrosine kinases: Implications for cellular transformation and tumor therapy , 1993, Journal of cellular biochemistry.

[2]  G. Staal,et al.  Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity. , 1993, Analytical biochemistry.

[3]  A. Wilks.  Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer. , 1993, Advances in cancer research.

[4]  J. Foekens,et al.  Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. , 1992, Cancer research.

[5]  G. Staal,et al.  Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. , 1992, Cancer research.

[6]  Umberto Veronesi,et al.  Breast cancer (Third of three parts) , 1992 .

[7]  J. Foekens,et al.  c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. , 1992, Cancer research.

[8]  T. Benraad,et al.  Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology. , 1992, European journal of cancer.

[9]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.

[10]  A. Levitzki,et al.  The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers , 1991, The Journal of cell biology.

[11]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[12]  R. Dickson,et al.  The EGF receptor system as a target for antitumor therapy. , 1991, Cancer investigation.

[13]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[14]  J. Foekens,et al.  Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. , 1989, Cancer research.

[15]  A. Sartorelli,et al.  Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix. , 1989, Cancer research.

[16]  M. Laiho,et al.  Growth factors in the regulation of pericellular proteolysis: a review. , 1989, Cancer research.

[17]  B. V. van Oirschot,et al.  Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. , 1989, Cancer research.

[18]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[19]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[20]  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute. , 1980, European Journal of Cancer.